PETRO USA, INC. (PBAJ) Financial Statements (2024 and earlier)

Company Profile

Business Address 7325 OSWEGO ROAD
LIVERPOOL, NY 13090
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2023
MRQ
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments100     
Cash and cash equivalents100     
Total current assets:100     
Noncurrent Assets
TOTAL ASSETS:100     
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:29,56821,08919,07515,2233,5006,000
Other undisclosed accounts payable and accrued liabilities29,56821,08919,07515,2233,5006,000
Debt4,0773,7953,512   
Due to related parties 79,65988,81375,67370,06153,842
Other undisclosed current liabilities94,861     
Total current liabilities:128,506104,543111,40090,89673,56159,842
Noncurrent Liabilities
Total liabilities:128,506104,543111,40090,89673,56159,842
Equity
Equity, attributable to parent(128,406)(104,543)(111,400)(90,896)(73,561)(59,842)
Common stock20,00320,0033296,418296,418296,418
Additional paid in capital121,677,146121,677,146121,677,146121,373,231121,373,231121,373,231
Accumulated deficit(121,825,555)(121,801,692)(121,788,549)(121,760,545)(121,743,210)(121,729,491)
Total equity:(128,406)(104,543)(111,400)(90,896)(73,561)(59,842)
TOTAL LIABILITIES AND EQUITY:100     

Income Statement (P&L) (USD)

12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
Operating expenses(23,581)(12,860)(27,992)(17,335)(13,719)(33,292)
Operating loss:(23,581)(12,860)(27,992)(17,335)(13,719)(33,292)
Nonoperating expense
(Other Nonoperating expense)
(282)(283)(12)   
Interest and debt expense(282)(283)(12)   
Loss from continuing operations:(24,145)(13,426)(28,016)(17,335)(13,719)(33,292)
Loss before gain (loss) on sale of properties:(13,426)(28,016)(17,335)(13,719)(33,292)
Other undisclosed net income282283    
Net loss:(23,863)(13,143)(28,016)(17,335)(13,719)(33,292)
Other undisclosed net income (loss) attributable to parent  12   
Net loss available to common stockholders, diluted:(23,863)(13,143)(28,004)(17,335)(13,719)(33,292)

Comprehensive Income (USD)

12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
Net loss:(23,863)(13,143)(28,016)(17,335)(13,719)(33,292)
Comprehensive loss, net of tax, attributable to parent:(23,863)(13,143)(28,016)(17,335)(13,719)(33,292)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: